期刊
CHEMISTRYSELECT
卷 2, 期 29, 页码 9532-9536出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/slct.201701940
关键词
enzyme inhibition; K36M; oncohistone; protein lysine methyltransferase; somatic cancer mutation
资金
- Deutsche Forschungsgemeinschaft [JE 252/8]
- Sander Foundation [2015.014.1]
Methylation of histone 3 (H3) at lysine K36 is catalyzed by the NSD1, NSD2 and SETD2 protein lysine methyltransferases (PKMTs). In cancers, somatic K36M mutations were observed and shown to inhibit NSD2 and SETD2. We conducted a comparative steady-state kinetic analysis of the inhibition of all three H3K36 specific PKMTs by an inhibitory H3 (27-43) peptide containing the K36M oncomutation. Our data show that NSD1 is also inhibited by the K36M mutation. With all three enzymes, we observed that the inhibition constant K-I is about 1.5 fold lower than the K-M for the corresponding substrate peptide indicating a better binding of the inhibitory peptide. This numerical similarity suggests a related mechanism of inhibition in all three cases in agreement with the conserved architecture of the active sites of these enzymes. The mechanism of inhibition of PKMTs by target lysine to methionine mutations is discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据